Please login or register to print this page.

VIEW TAGS

Articles tagged ‘anticoagulants’

July 30, 2015

NOACs carry different bleeding risks for elderly

Non-vitamin K antagonist oral anticoagulants (NOACs) have equal efficacy to older treatments, but carry different risk of bleeding complications in the elderly, finds a study published recently in Circulation.1

read more

August 5, 2014

Apixaban versus warfarin and aspirin: results from AVERROES and ARISTOTLE

The efficacy and safety of apixaban compared with aspirin are consistent in subgroups of patients who have previously attempted but failed Vitamin K antagonist (VKA) therapy, irrespective of the reason for discontinuation, according to a study published recently in the European Heart Journal.1

read more

September 18, 2013

News from EHRA

In the latest British Journal of Cardiology, Dr James Rosengarten (Wessex Electrophysiology Fellow and BJCA Deanery Representative) reports highlights from the European Heart Rhythm Association (EHRA) Europace 2013 meeting held recently in Athens, Greece.

read more

August 30, 2013

A call for monitoring for AF in post-stroke patients

Routine noninvasive cardiac-event monitoring after acute stroke enhances detection of paroxysmal atrial fibrillation (AF) and early anticoagulation, according to a study1 published recently in Stroke.

read more

August 30, 2013

Risks of aspirin with oral anticoagulation in patients with AF

Patients with atrial fibrillation (AF) receiving oral anticoagulation (OAC) are often treated with concomitant aspirin (ASA) therapy, even when they do not have cardiovascular disease, according to a study1 published recently in Circulation. Use of OAC and ASA was associated with significantly increased risk for bleeding, say the authors

read more

December 20, 2012

Benefits of NOACs in AF

Novel oral anticoagulants (NOACs) are associated with an overall clinical benefit compared with vitamin K antagonists, according to a study1 published recently in Circulation.

read more

November 15, 2012

OAC underutilised in patients with AF

Oral anticoagulant (OAC) use in patients with atrial fibrillation (AF) has increased in UK practice since 2007, but remains suboptimal in current practice, according to a study1 published recently in the British Journal of General Practice.

read more

November 15, 2012

NOACs in AF – review and analysis

Novel oral anticoagulants (NOACs) are associated with an overall clinical benefit compared with vitamin K antagonists, according to a study1 published recently in Circulation.

read more

June 25, 2012

In vitro approaches to reversal of anticoagulant, apixaban, explored

Three approaches may reverse the activity of the new oral anticoagulant apixaban, when a person needs emergency surgery, for example, according to laboratory research presented in the American Heart Association’s Emerging Science Series webinar.1

read more

September 7, 2011

DABIGATRAN LICENSED IN UK

A new oral anticoagulant, dabigatran etexilate (Pradaxa®, Boehringer Ingelheim), has been made available in the UK. Following the EU licence for dabigatran, granted on 1st August 2011,1 a recommended dose of 150 mg twice daily is now licensed in the UK for the prevention of stroke and systemic embolism in eligible adult patients with AF.

read more

Older articles »

Members Area

Log in or Register now.

 For healthcare professionals only
Angina book sky

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.